Monteliz Suspension

Monteliz Suspension

Montelukast – inhibits cysteinyl leukotriene receptors of the respiratory epithelium, thereby simultaneously having the ability to inhibit bronchospasm caused by inhaled cysteinyl leukotriene LTD4 in patients with bronchial asthma.


every 5 ml contains:

  • Montelukast sodium BP eq. montelukast 4 mg;
  • Levocetirizine dihydrochloride USP 2.5 mg;
  • Flavored syrup base q.s.
  • Approved dye used.
  • treatment of symptoms of year-round and seasonal allergic rhinitis (including persistent allergic rhinitis) and allergic conjunctivitis, sneezing, rhinorrhea, lacrimation, conjunctival hyperemia;
  • prevention and long-term treatment of bronchial asthma.

Inside, during meals or on an empty stomach.
The recommended dose for adults and children over 6 years of age, elderly patients (provided normal renal function) is 10 ml 1 time per day.
Children from 2 to 6 years old – 5 ml once a day.

The course of treatment is 14 days.